Literature DB >> 16951894

[Survival study of breast cancer patients treated at the hospital of the Federal University in Santa Maria, Rio Grande do Sul, Brazil].

Anaelena Bragança de Moraes1, Roselaine Ruviaro Zanini, Marcelo Scalvenzi Turchiello, João Riboldi, Lídia Rosi de Medeiros.   

Abstract

This retrospective hospital-based study aimed to describe health conditions and to estimate the survival of 252 patients diagnosed with breast cancer and treated at the Mastology Outpatient Clinic at the University Hospital of the Federal University in Santa Maria, Rio Grande do Sul, Brazil, from 1980 to 2000. Analysis followed the Kaplan-Meier and Cox model. Mean age was 54, and 73.4% of the patients had a histological diagnosis of invasive ductal carcinoma, 63.9% showed no lymph node involvement, and 57.6% were clinical stage II. At the end of the study, 64.7% were alive and free of breast cancer and 5.1% had died of other causes. Five-year survival was 87.7% for all women, and prognostic factors associated with survival were tumor size (HR = 12.03; > 5cm), lymph node involvement (HR = 3.08; N1) and number (HR = 4.66; None), and estrogen (HR = 0.34) and c-erbB-2 (HR = 2.51) receptors. Based on the results, intensive awareness-raising campaigns are vitally important for implementing breast cancer screening to achieve early diagnosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951894     DOI: 10.1590/s0102-311x2006001000028

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  10 in total

Review 1.  A review of breast cancer care and outcomes in Latin America.

Authors:  Nahila Justo; Nils Wilking; Bengt Jönsson; Silvana Luciani; Eduardo Cazap
Journal:  Oncologist       Date:  2013-02-26

2.  CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.

Authors:  Karen Brajão de Oliveira; Julie Massayo Maeda Oda; Julio Cesar Voltarelli; Thiago Franco Nasser; Mario Augusto Ono; Thiago Cezar Fujita; Tiemi Matsuo; Maria Angelica Ehara Watanabe
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  Quality of life as a predictor of overall survival after breast cancer treatment.

Authors:  Suzana Sales De Aguiar; Anke Bergmann; Inês Echenique Mattos
Journal:  Qual Life Res       Date:  2013-07-20       Impact factor: 4.147

4.  Effect of Agaricus sylvaticus supplementation on nutritional status and adverse events of chemotherapy of breast cancer: a randomized, placebo-controlled, double-blind clinical trial.

Authors:  Fabiana Valadares; Maria Rita Carvalho Garbi Novaes; Roberto Cañete
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200

5.  Functionality in Women with Breast Cancer: The Use of International Classification of Functioning, Disability and Health (ICF) in Clinical Practice.

Authors:  Flávia Nascimento de Carvalho; Anke Bergmann; Rosalina Jorge Koifman
Journal:  J Phys Ther Sci       Date:  2014-05-29

6.  Association between poor clinical prognosis and sleep duration among breast cancer patients.

Authors:  Thalyta Cristina Mansano-Schlosser; Maria Filomena Ceolim
Journal:  Rev Lat Am Enfermagem       Date:  2017-06-05

7.  Prevalence of dermatological complaints in patients undergoing treatment for breast cancer.

Authors:  Tamara Hoffmann; Mariane Corrêa-Fissmer; Camila Soares Duarte; Rayane Felippe Nazário; Ana Beatriz Sanches Barranco; Karen Waleska Knipoff de Oliveira
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

8.  A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort).

Authors:  Maira Caleffi; Rodrigo A Ribeiro; Dakir L Duarte Filho; Patrícia Ashton-Prolla; Ademar J Bedin; Giovana P Skonieski; Juliana M Zignani; Juliana Giacomazzi; Luciane R Franco; Márcia Graudenz; Paula Pohlmann; Jefferson G Fernandes; Philip Kivitz; Bernardete Weber
Journal:  BMC Public Health       Date:  2009-03-13       Impact factor: 3.295

9.  Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital--a closer look into cause-specific mortality.

Authors:  Débora Balabram; Cassio M Turra; Helenice Gobbi
Journal:  BMC Cancer       Date:  2013-09-24       Impact factor: 4.430

10.  Analysis of breast cancer survival in a northeastern Brazilian state based on prognostic factors: A retrospective cohort study.

Authors:  Adriane Dórea Marques; Alex Rodrigues Moura; Evânia Curvelo Hora; Érika de Abreu Costa Brito; Leonardo Souto Oliviera; Ionara Rodrigues Feitosa; Flavia Fernandes Freitas; Marcela Sampaio Lima; Íkaro Daniel de Carvalho Barreto; Marceli Oliveira Santos; Angela Maria da Silva; Carlos Anselmo Lima
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.